Skip to main content
Premium Trial:

Request an Annual Quote

Evonetix Extends DNA Synthesis Partnership With Semiconductor Firm Analog Devices

NEW YORK — Evonetix said on Wednesday that it has extended its partnership with semiconductor firm Analog Devices to develop new DNA synthesis products.

Under the terms of the deal, the companies will collaborate on the development and commercial scaleup of Evonetix's proprietary microelectromechanical systems (MEMS)-based silicon chips, which are designed to synthesize DNA within thousands of independently controlled reaction sites.

The companies will also work together to advance Evonetix's first product, a desktop DNA synthesizer, which Norwood, Massachusetts-based Analog will manufacture.

UK-based Evonetix said it began working with Analog's innovation lab, Analog Garage, in January 2019 to develop an integrated product that includes the MEMS technology, an application-specific integrated circuit (ASIC), and flow cell.

"The support and expertise of the Analog Garage R&D team has been invaluable in helping us design a complex control ASIC, and we now look forward to expanding our collaboration to achieve the commercial scale-up of our platform," Evonetix Chief Technology Officer Matthew Hayes said in a statement.

In March, Evonetix raised £23 million ($30.0 million) in Series B funding.

The Scan

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.

Vitamin D From Tomatoes

According to Reuters, researchers in the UK have gene-edited tomatoes so their fruit contains vitamin D.

Cause Not Yet Spotted

NPR reports that a new study was unable to find a cause for persistent long COVID symptoms.

PNAS Papers on Central African Hunter-Gatherers, Myopia Development, Ancient Microtia Allele

In PNAS this week: population patterns among Central African hunter gatherers, effect of myopia-linked gene variant, and more.